Genio Technologies, Inc.

company

About

MS Pen Technologies specializes in the application of the MasSpec Pen, a novel probe which enables real-time biochemical analysis.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$1.25M
Industries
Health Diagnostics
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

The MasSpec Pen is a handheld pen-like device that rapidly identifies the molecular profile of tissues using a small volume water droplet and mass spectrometry analysis. After 3 seconds of gentle physical contact with a tissue surface, the water droplet is transported to a mass spectrometer, which characterizes diagnostic proteins, lipids, and metabolites. Using machine learning algorithm, a diagnosis is provided with an associate probability of presence of cancer. The pen could be used to rapidly distinguish tumor from healthy tissue during surgery in mice, without requiring specific labeling or imaging and without evidence of tissue destruction.

President and CEO: Shannon D. Green

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.25M
Genio Technologies, Inc. has raised a total of $1.25M in funding over 2 rounds. Their latest funding was raised on Jan 23, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 23, 2020 Seed $1.25M 1 i2E Management Company Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Genio Technologies, Inc. is funded by 1 investors. i2E Management Company are the most recent investors.
Investor Name Lead Investor Funding Round
i2E Management Company Yes Seed